Background Fosfomycin is increasingly called upon for the treatment of multi drug-resistant
(MDR) organisms causing urinary tract infection (UTI). We reviewed oral fosfomycin use for …

Background: Bacterial resistance among uropathogens is on the rise and has led to a
decreased effectiveness of oral therapies. Fosfomycin tromethamine (fosfomycin) is …

Fosfomycin is recommended as one of the first-line agents for treatment of urinary tract
infections (UTIs) in the latest guidelines endorsed by the Infectious Diseases Society of …

Fosfomycin has shown promising in vitro activity against multidrug-resistant (MDR) urinary
pathogens; however, clinical data are lacking. We conducted a retrospective chart review to …

Among 47 patients with urinary tract infections (UTIs) due to multidrug-resistant (MDR)
bacteria, treatment with fosfomycin resulted in clinical cure rates of 87% and 94% at 48 …

Objectives Limited options for treating MDR organisms have led clinicians to turn to older
antimicrobial agents that may display activity against such infections. One such agent is …

Fosfomycin, approved in the United States only for cystitis, is an attractive alternative for oral
treatment of outpatient complicated urinary tract infections (cUTIs) as it has antimicrobial …

Urinary tract infections are one of the most common health problems and entail a high
consumption of health system resources. Due to the increase in global antibiotic resistances …

Introduction Increased emergence of bacterial resistance and the limited options of novel
antimicrobial agents have necessitated the reintroduction of some old antimicrobial agents …

Background: Increasing antimicrobial resistance is a major problem worldwide. Many
urinary tract infection (UTI) isolates are resistant to all oral antimicrobial agents …